跳至主要内容
临床试验/IRCT20201108049311N8
IRCT20201108049311N8尚未招募3 期

The secretome of pre-conditioned placenta-derived mesenchymal stem cells as an antimicrobial lock in hemodialysis patients with catheter infection: A triple-blinded randomized clinical trial

Tabriz University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 80 years(—)
性别
All

入选标准

  • Patients with end-stage kidney disease under hemodialysis for at least six month and permanent catheter infection with diagnosis of blood culture and clinical symptoms
  • Age between 18 and 80 years
  • Willingness to participate in the study
  • Under hemodialysis for two or three times a week

排除标准

  • Having symptoms of severe sepsis such as decreased level of consciousness and low blood pressure
  • Having a temporary catheter
  • Having symptoms of acute thromboembolism

研究者

相似试验